Scientists have developed an implantable device that acts as a 'living pharmacy', using engineered cells to continuously ...
An exploratory analysis of the phase 2 ALYCANTE trial (NCT04531046) reveals that patients with relapsed/refractory large ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results